polysaccharide was shown by chondroitinase ABC digestion to be 70 % chondroitin 4-sulphate and 30% chondroitin. The molecular size of this newly synthesized glycosaminoglycan was determined by gel filtration to be larger than 40000 mol.wt. In general, the glycosaminoglycan-synthesizing ability of the microsomal preparations appeared to reflect glycosaminoglycan synthesis by the intact cells.
UDP-[14C]glucuronic acid, and UDP-N-acetylgalactosamine. The resulting newly synthesized polysaccharide was shown by chondroitinase ABC digestion to be 70 % chondroitin 4-sulphate and 30% chondroitin. The molecular size of this newly synthesized glycosaminoglycan was determined by gel filtration to be larger than 40000 mol.wt. In general, the glycosaminoglycan-synthesizing ability of the microsomal preparations appeared to reflect glycosaminoglycan synthesis by the intact cells.
Cell-free biosynthesis of the polysaccharide portions of proteoglycans has been obtained by the use of microsomal preparations from several animal tissues, including chick embryo cartilage (Silbert, 1964; Perlman et al., 1964; DeLuca & Silbert, 1968; Silbert & DeLuca, 1969) , mouse mastocytoma (Silbert, 1963 (Silbert, , 1967a Lindahl et al., 1972) , rat skin (Schiller et al., 1961) , rabbit marrow cells (Olsson, 1972) and horse leucocytes (Olsson & Gardell, 1971) . These studies have established that uridine sugar nucleotides are the precursors for the polymerization of the heteropolysaccharide chains and confirmed that adenosine 3'-phosphate 5'-sulphatophosphate is the sulphate donor required for extensive sulphation.
Much less is known about the enzymes and acceptors involved, or about the interrelationships between the various steps in glycosaminoglycan synthesis and regulation. There have been certain difficulties in approaching these questions, owing to the limitations inherent in studies with preparations from whole tissues. In general, whole tissues are heterogeneous, containing not only the desired cells but also extracellular matrix and small amounts of other elements such as blood vessels, fibroblasts etc. Moreover, the ability to control the cellular environment is limited with the use of whole tissues. In conVol. 134 trast to whole tissues, cultured cell systems in vitro have the advantages ofhomogeneity, low extracellular matrix content and controllable environment.
In the present study, various lines of mouse mastocytoma-derived cells, previously analysed for their glycosaminoglycan -synthesizing activities (Lewis et al., 1973) , were grown in vitro in quantities large enough to enable the preparation of microsomal fractions. The glycosaminoglycan-biosynthesizing abilities of these microsomal preparations were determined. The macromolecular products synthesized from the appropriate precursors by these preparations were found to be generally consistent with the glycosaminoglycan products produced by intact cells.
Experimental

Materials
The following materials were obtained from the indicated sources: culture medium, horse serum and antibiotics, Grand Island Biological Co., Grand Island, N.Y., U.S.A.; polyvinylpyrrolidone (Grade 40), Schwarz/Mann, Orangeburg, N.J., U.S.A.; spinner flasks, Bellco Co., Vineland, N.J., U.S.A.; Mes [2-(N-morpholino) (Silbert, 1964 (Silbert, , 1967a . Sources of other materials are given in the preceding paper (Lewis et al., 1973) .
Methods
Culture techniques. Mastocytoma cells (as described by Lewis et al., 1973) were grown in large-volume suspension cultures, by using spinner flasks containing Fischer's medium supplemented with 10% (v/v) horse serum, 0.1 % (w/v) polyvinylpyrrolidone, penicillin (100 units/ml) and streptomycin (100,ug/ml). The medium was equilibrated with CO2 + air (5:95) throughout the culture period. Each culture was initiated by inoculating a 1-litre spinner flask containing 400ml of growth medium with enough cells to give an initial culture density of approx. 20000-40000 cells/ml. After 3 days' culture, the contents of this flask were used to seed another spinner flask (9 litre) containing 6 litres of medium. After another 3-4-day culture period, the cells were separated from the medium by centrifugation (400g (Lowry et al., 1951) . UDP-N-acetylglucosamine, and adenosine 3'-phosphate 5'-sulphatophosphate. Unless otherwise noted, the reaction mixtures were in a volume of 25,ul and were incubated at 37°C for 2h.
Labelled glycosaminoglycan products were isolated by the procedure of DeLuca & Silbert (1968) . Reaction mixtures were chromatographed on Whatman no. 1 paper in ethanol-i M-ammonium acetate, pH 7.5 (5:2, v/v). The chromatographic origins, which contained all the macromolecular material, were cut out and incubated overnight at 37°C with 2ml of 0.05M-Tris-HCI buffer (pH8.5) containing 1 % (w/v) pancreatin. Several drops of toluene were added to retard bacterial growth. After incubation, the suspensions were boiled and centrifuged (20000g) for 30min. The supernatants were retained and the pellets were resuspended in 1 M-NaCl and re-centrifuged. The supernatants were then combined and dialysed against several changes of water and the non-diffusible material was assayed for radioactivity.
Characterization of glycosaminoglycans. The characterization procedures used in this study are described in detail in the preceding paper (Lewis et al., 1973) .
Samples of the labelled materials, along with standard chondroitin sulphate, were treated with testicular hyaluronidase. After enzymic treatment, the reaction mixtures were placed on columns (1cm x 15 cm) of Sephadex G-50 and eluted with 1 M-NaCl. The amount of material appearing in the included fractions was considered to represent the degraded glycosaminoglycan.
Other samples, together with standard chondroitin sulphates, were incubated with chondroitinase ABC. After degradation, the reaction products were chromatographed overnight on Whatman no. 1 paper in butan-1-ol-acetic acid-I M-aq. NH3 (2: 3: 1, by vol.).
For estimation of molecular weight, samples were placed on columns (1 cm x 60cm) of Sepharose 4B with a standard of chondroitin 6-sulphate (mol.wt. 40000) and eluted with 0.1 M-LiCl.
Analytical methods
The methods of analysis used in this paper were described previously (Lewis et al., 1973) . Radioactivity was determined with a liquid-scintillation spectrometer or a low-background (0.5 c.p.m.) planchet counter. Culture cell densities were determined with a haemocytometer.
Results
Large-volume culture of mastocytoma-derived cells All the cell lines previously studied for glycosaminoglycan-synthesizing potential (Lewis et al., 1973) grew well under the suspension culture conditions used in the present study. The average final culture density for five cell lines grown in this fashion was 6.5 x 105 cells/ml, yielding an average of approx. 7.Oml of packed cells. Therefore, the large quantities of cells necessary for subcellular studies were readily obtainable.
Glycosaminoglycan formation
Microsomal preparations from the cells were tested for heteropolysaccharide-polymerizing activities. (Silbert, 1963 (Silbert, , 1964 3 . Charge densities of 14C-labelled glycosaminoglycan synthesized by P815S microsomal preparations in the presence or in the absence ofadenosine 3'-phosphate 5'-sulphatophosphate Macromolecular materials were chromatographed on DEAE-cellulose columns by using a logarithmic [LiCl] gradient (see solid line in a). Fractions (2.5 ml) were collected. The reservoir was changed from 1 M-to 2M-LiCl after fraction 80. The positions of standard glycosaminoglycans were determined by assay for uronic acid. Fractions were pooled as indicated, dialysed, freeze-dried and characterized further (Table 3) . (a) Standards; (b) no adenosine 3'-phosphate 5'-sulphatophosphate; (c) with adenosine 3'-phosphate 5'-sulphatophosphate. Vol. 134
Glycosaminoglycan synthesized by P815S microsomal preparations was also treated with chondroitinase ABC and the resulting degradation products were chromatographed. The [14C]glycosaminoglycan, synthesized in the reaction mixtures that did not contain adenosine 3'-phosphate 5'-sulphatophosphate, was degraded to material co-chromatographing with ADi-OS (Fig. 2) . This further supported the identification of the heteropolysaccharide as chondroitin. Approx. 3-4% of this chondroitinase-degraded material chromatographed in the position of the C) 01u saturated disaccharide acetyichondrosine (Di-OS). Since the saturated disaccharide would represent the non-reducing terminal of the chondroitin chain, this suggests that the additional, newly synthesized chains contained an average of 25-33 disaccharide repeating units. When adenosine 3'-phosphate 5'-sulphatophosphate was included in the reaction mixture, the [14C]glycosaminoglycan product was different. Only 30% of products of degradation by chondroitinase co-chromatographed with ADi-OS, whereas 70 % co-chromatographed with ADi-4S (Fig. 2) . No 20 30 Fraction no. Fig. 4 . Sepharose 4B gel chromatography of 14C-labelled glycosaminoglycans synthesized by P815S microsomal preparations After DEAE-cellulose chromatography (Fig. 3) , pooled materials along with standard chondroitin 6-sulphate (mol.wt. 40000) were chromatographed on Sepharose 4B. Fractions (1.0ml) were collected and samples were analysed for radioactivity (-) Labelled products synthesized by microsomal preparations from P815S cells were analysed further by ion-exchange chromatography on DEAE-cellulose (Fig. 3) . Glycosaminoglycan synthesized in the presence of adenosine 3'-phosphate 5'-sulphatophosphate had an elution pattern different from the elution pattern of glycosaminoglycan formed in the absence of adenosine 3'-phosphate 5'-sulphatophosphate, demonstrating the change in charge densities owing to the sulphation of chondroitin. The peak III material (Fig. 3) had a charge density greater than that of the chondroitin 4-[35S]sulphate formed by intact P815S cells (Lewis et al., 1973) . Fully sulphated materials formed by microsomal preparations from chick cartilage have also been noted to have the same high charge density (Silbert & DeLuca, 1969) .
Pooled, dialysed fractions from the DEAE-cellulose columns were treated with chondroitinase ABC (Table 2) . Degradation of peak I material gave ADi-OS, indicating that the peak I glycosaminoglycan was chondroitin. Degradation of peak II and III materials yielded 67% and 96% ADi-4S respectively, indicating that sulphation of the chondroitin had occurred to form chondroitin 4-sulphate.
The molecular size relative to standard commercial chondroitin 6-sulphate (mol.wt. 40000) of these DEAE-cellulose-separated materials was estimated by Sepharose 4B gel filtration (Fig. 4) . Peak I and peak III material chromatographed in a position indicating a larger size than the standard, whereas peak II material appeared to have an average size similar to the standard.
Discussion
Microsomal preparations from cells of three mouse mastocytoma lines (P815Y, X163 and P815S) cultured in vitro contained sufficient glycosaminoglycan-synthesizing activity for further study.
Microsomal preparations from both P815Y and P815S cells, when incubated with the appropriate sugar nucleotides, synthesized chondroitin but no heparin-like glycosaminoglycan. In a further study, the microsomal preparations of P815S cells were shown to have sulphating activity; 70 % of the newly synthesized chondroitin was sulphated to form chondroitin 4-sulphate when adenosine 3'-phosphate 5'-sulphatophosphate was present. The chondroitin 4-sulphate heteropolysaccharide synthesized by the cell-free system was larger than a chondroitin sulphate standard (of mol.wt. 40000), and larger than the chondroitin 4-sulphate formed by intact P815S cells (Lewis et al., 1973) . The significance of these size differences is not known.
Microsomal preparations from X163 cells incorporated sugars into both heparin-like and chondroitin-like glycosaminoglycans. In this case, the expression of the glycosaminoglycan-synthesizing potential of X163-cell microsomal preparations appeared to be modified by the loss ofthe intracellular environment, since intact XI 63 cells produced predominantly heparin-like material (Lewis et al., 1973) .
It is of interest to compare the results of this study with those of earlier experiments, which used microsomal preparations from whole mastocytoma tissue (Silbert, 1963 (Silbert, , 1967a . Previously, microsomal preparations from P815 mouse mastocytomas were shown to synthesize non-sulphated and sulphated heparin-like materials. However, in these earlier experiments, chondroitin sulphate-synthesizing potential was not investigated. Our present studies have shown that microsomal preparations from these mastocytomas now have chondroitin-synthesizing activity and less heparin-synthesizing activity than previously observed. It seems that after years of repeated transplantations there have been changes in the glycosaminoglycan-synthesizing potential of the tumour line.
Cell-free synthesis of highly sulphated chondroitin sulphate de novo has been previously demonstrated only with microsomal preparations from chick embryo cartilage (Silbert & DeLuca, 1969) . Subsequently, these products have been identified as entirely chondroitin 6-sulphate (S. DeLuca, M. Richmond & J. Silbert, unpublished work). The present work with microsomal preparations from P815S cells has demonstrated the first cell-free synthesis of chondroitin 4-sulphate de novo.
